Side effects of Eltrombopag mainly include gastrointestinal disturbances such as nausea, vomiting and dyspepsia, but also thrombocytopenia and bleeding tendencies such as skin petechiae, conjunctival hemorrhages, and menorrhagia. Some patients may also experience abnormal liver function, muscle pain and sensory abnormalities. Eltrombopag belongs to the thrombopoietin receptor agonists, mainly used in the treatment of chronic thrombocytopenia, such as idiopathic thrombocytopenia, etc. It is often used in the treatment of patients who do not respond well to hormones, splenectomy and other treatments. Adverse reactions include gastrointestinal discomfort, bleeding tendency and other manifestations. 1. Gastrointestinal discomfort: nausea, vomiting, dyspepsia. 2. Bleeding tendency: thrombocytopenia, skin ecchymosis, conjunctival bleeding, menorrhagia. 3. Other manifestations: abnormal liver function, muscle pain and abnormal sensation. Such drugs are recommended to be used under medical supervision, contraindications include patients with severe hepatic and renal impairment and patients with allergy to the product, and regular monitoring of blood counts and liver function during use.